WDR64 Inhibitors

WDR64 inhibitors encompass a diverse range of compounds that influence the activity or function of the WDR64 protein by targeting various signaling pathways and cellular processes. These inhibitors exert their influence through the modulation of pathways and processes that are either upstream or downstream of WDR64's functional role within the cell. The inhibitors include compounds that target key signaling molecules like mTOR, PI3K, MEK, p38 MAP kinase, JNK, ROCK, AMPK, IKK, and Src family kinases. These molecules are integral components of pathways that govern essential cellular functions such as cell growth, survival, metabolism, inflammation, stress responses, cytoskeleton dynamics, and immune responses. By modulating these signaling molecules, the inhibitors can indirectly affect the cellular context in which WDR64 operates, thereby potentially modulating its activity or the outcomes of its function.

For instance, rapamycin's inhibition of mTOR can impact cell growth and proliferation pathways, which may intersect with WDR64's functions. Similarly, compounds like LY 294002 and Wortmannin, which inhibit PI3K, alter signaling pathways involved in cell survival and metabolism. This alteration could create a cellular environment that influences WDR64's activity. MEK inhibitors such as U0126 and PD 98059 affect the MAPK/ERK pathway, which is critical in transmitting signals from growth factors and other external stimuli to the cell's nucleus. The modulation of this pathway can have ripple effects on processes where WDR64 is involved. Moreover, compounds like SB 203580, SP600125, and BAY 11-7082 target various aspects of the inflammatory response and stress response pathways. By influencing these pathways, they could affect the cellular processes associated with WDR64. Y-27632 and BML-275, which target ROCK and AMPK respectively, impact cytoskeleton dynamics and energy balance.